Komori
Governance4599StemRIM Inc.Pharmaceuticals

Corporate Governance Report 2026/10/29

The company reports its corporate governance framework and timely disclosure framework. The Board of Directors comprises 4 directors, the Audit & Supervisory Board comprises 3 audit & supervisory board members, and a compensation committee has been established.

Worth reading
48Recurring
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Governance structure

Company with an Audit & Supervisory Board
Number of directors4 directors (including 2 outside directors)
Committee1
Compensation Committee
Percentage of outside members 2 outside members / 3 directors; outside members account for approximately 66.7%
Governance structure
ItemDetails
Corporate Governance StructureCompany with an Audit & Supervisory Board
Number of directors4 directors (including 2 outside directors)
CommitteeCompensation Committee (2 outside members / 3 directors; outside members account for approximately 66.7%)
Items this document does not state (5)
Number of independent officersPolicy on cross-shareholdingsTakeover defensesControlling shareholderChanges this time

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To present the corporate governance structure and timely disclosure system.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Corporate Governance Report 2026/10/29 | StemRIM Inc. (4599) timely disclosure | Komori